ARCHIVES

Facilities Survey: $2.5 Billion Will Be Required From 1986-1990, With NCI’s Share At $678 Million

This article is from The Cancer Letter archive.

Vol. 11 No. 15 | April 12, 1985

Download PDF Visit The Full Archive

Related Articles

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

In Brief: Benacerraf, Snell, Dausset Win Nobel Prize; AACE Seeks Increase In Clinical Education Funds

October 17, 1980

In Brief: NCAB Approves Concept Of Converting Baltimore Program To Cancer Center; New DCCP Labs Named

June 5, 1981

Race, Age Play Role In Delay Of Surgery For Breast Cancer

December 28, 2007

First Phase 0 Oncology Trial Demonstrates Effectiveness Of New Drug On Its Target

April 24, 2009

New Grants In Ovarian Cancer Ok’d In Concepts By DCBDC Advisors

March 27, 1992